C23H17N5O3
Neat
411.42
911417-62-4; 2-(3-(4-((1H-indazol-5-yl)amino)quinazolin-2-yl)phenoxy)acetic acid; Belumosudil metabolite M2; 4SQ6Q2M5KV; 2-[3-[4-(1H-indazol-5-ylamino)quinazolin-2-yl]phenoxy]acetic acid; Acetic acid, 2-[3-[4-(1H-indazol-5-ylamino)-2-quinazolinyl]phenoxy]-; 2-(3-(4-(1H-indazol-5-ylamino)quinazolin-2-yl)phenoxy)acetic acid; 2-[3-[4-(1H-Indazol-5-ylamino)-2-quinazolinyl]phenoxy]acetic acid; Acetic acid and 2-(3-(4-(1H-indazol-5-ylamino)-2-quinazolinyl)phenoxy)-; Besudil Impurity 2; Belumosudil Impurity 12; UNII-4SQ6Q2M5KV; SCHEMBL877239; SCHEMBL30743053; UHUDLFMBGUWKOR-UHFFFAOYSA-N; C23H17N5O3; DTXSID501168094; CS-M2493; D77469; 2-(3-(4-((1H-indazol-5-yl)amino)quinazolin-2-yl)phenoxy)aceticacid
2-[3-[4-(1H-indazol-5-ylamino)quinazolin-2-yl]phenoxy]acetic acid
InChI=1S/C23H17N5O3/c29-21(30)13-31-17-5-3-4-14(11-17)22-26-20-7-2-1-6-18(20)23(27-22)25-16-8-9-19-15(10-16)12-24-28-19/h1-12H,13H2,(H,24,28)(H,29,30)(H,25,26,27)